✦ LIBER ✦

Interim Results Presented at EASL From PROVE 1 Clinical Trial of Investigational Drug Telaprevir in Patients with Genotype 1 Hepatitis C

✍ Scribed by Les Lang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Results of Phase III Clinical Trials

✍ Jean–Michel Pawlotsky 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 888 KB

Comparison of daily interferon ALFACON-1

✍ S. Zeuzem; M. Manns; V. Rustgi; S. Aurora; C. Smith; M. Shiffman; R. Reddy; R. R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 132 KB

751d SVR Results of Prove3, a Phase 2B C

✍ Adrian M. Di Bisceglie; Andrew M.J. Muir; Nathalie Adda; Ira M. Jacobson; Nezam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB

1044 TELAPREVIR IN HEPATITIS C GENOTYPE-

✍ Manns, M.; Muir, A.; Adda, N.; Jacobson, I.; Afdhal, N.; Heathcote, J.; Zeuzem, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 91 KB

OC.03.1 EARLY DYNAMIC EVALUATION OF THE

✍ Di Paolo, D.; Ceccherini-Silberstein, F.; Cento, V.; Cucchiarelli, S.; Francioso 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 91 KB

The results of a randomized trial lookin

✍ C. Brandão; A. Barone; F. Carrilho; A. Silva; M. Patelli; C. Caramori; R. Focacc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB